In 2021, the Global Inhaled Nitric Oxide Delivery Systems market was estimated to be worth around USD 273.7 million.
With the increasing expenditure incurred on treating respiratory diseases with Inhaled Nitric Oxide Delivery Systems worldwide, the market is expected to reach a worth of about USD 735.7 million by the end of 2032, with a projected CAGR of 9.5% from 2022 to 2032. From 2017 to 2021, the Inhaled Nitric Oxide Delivery Systems Market experienced a growth of 8.5%.
| Attributes | Details |
|---|---|
| Global Inhaled Nitric Oxide Delivery Systems Market Size (2021) | USD 273.7 million |
| Global Inhaled Nitric Oxide Delivery Systems Market Size (2022) | USD 297.3 million |
| Projected Market Value (2032) | USD 735.7 million |
| Global Market Growth Rate (2022 to 2032) | 9.5% CAGR |
| United States Inhaled Nitric Oxide Delivery Systems Market (2022) | USD 104.7 million |
| Key Companies Profiled | Mallinckrodt Pharmaceuticals; Getinge; Vero Biotech; LINDE; Beyond Air; SLE; NU MED; Bellerophon Therapeutics; Air Liquide Healthcare; Circassia Pharmaceuticals |
More than 50% of patients with respiratory diseases need hospital admission. Increased Research and Development efforts that result in novel applications for inhaled nitric oxide delivery systems in the healthcare sector are the key factor fuelling the growth of the global inhaled nitric oxide delivery systems market. In addition, an aging population with weakened lung function drives the demand for inhaled nitric oxide delivery systems globally.
Nitric oxide inhalation (INO), a minimally invasive therapy, is becoming more popular, which is causing the market to grow. Research conducted in 2020 revealed that inhaled nitric oxide is effective in treating SARS-CoV-2 infection. Like traditional medications, it is also a successful therapy for COVID-19 patients. As a result, during the pandemic, there was a sharp increase in demand for inhaled nitric oxide delivery systems.
Additionally, ARDS (acute respiratory distress syndrome), a symptom in COVID-19 patients, is well treated with inhaled nitric oxide delivery systems. INO helps COVID-19 patients by increasing oxygen circulation. These factors are therefore expected to improve the opportunities for market growth for inhaled nitric oxide delivery systems. Important market participants like Mallinckrodt Pharmaceuticals are sponsoring more clinical trials of inhaled nitric oxide therapy.
During the following ten years, these activities will also drive the market's expansion. The year 2020 saw an overwhelming demand for Inhaled Nitric oxide delivery systems due to increasing cases of Covid-19.
North America holds the largest market for Inhaled Nitric Oxide Delivery Systems and is likely to grow at a rapid pace in the next 10 years. This growth is because of the increasing cases of HRF in the region. In addition to this, the rising adoption of INO therapy, the presence of advanced medical infrastructure, and favorable government initiatives are expected to bolster growth avenues in the market.
Asthma affects more than 25 million people in the USA. 12 million adults have not yet received a COPD diagnosis, despite there being 14.8 million adults with the condition. In the USA, phase two and phase three clinical trials of inhaled nitric oxide for acute respiratory distress syndrome use the inhaled nitric oxide delivery method on a regular basis.
In 2020, more than 300,000 deaths from respiratory disorders were recorded in Canada. Five significant respiratory disorders, including asthma, chronic obstructive pulmonary disease (COPD), lung cancer, tuberculosis (TB), and cystic fibrosis, afflict the majority of Canadians. As these illnesses become more prevalent, the need for inhaled nitric oxide delivery systems in the area is growing along with them.
Asia Pacific has the fasted growing market for Inhaled Nitric Oxide Delivery Systems. This is mainly due to the increasing pollution and growing pediatric population in the region.
In Asia Pacific, China accounts for the largest share of the market for Inhaled Nitric Oxide Delivery Systems followed by India. This is because COPD is rapidly becoming recognized as a severe health issue in China. According to estimations, 8.2% of Chinese people have COPD, and the disease's death rate is around 1.6%.
In India, respiratory infections caused 41,996,260 illnesses and 3,740 deaths in 2018, according to the National Health Portal of India. Severe acute respiratory infections (SARI) are one of the leading causes of death in children under the age of five, accounting for 18% of the global population in India. As a result, there is a sharp rise in the demand for inhaled nitric oxide delivery systems in the country.
The USA holds the largest market for Inhaled Nitric Oxide Delivery Systems, which is projected to reach a valuation of USD 258.4 million by 2032. From 2017 to 2021, the market in the US grew at a CAGR of 8.8%. Between 2022 and 2032, the US is expected to be a market with a USD 153.7 million absolute dollar opportunity.
Since there are between 64.2 and 78.9 cases of ARDS per 100,000 people per year in the US, there exists a significant demand for Inhaled Nitric Oxide Delivery systems. Around 25% of ARDS patients are initially categorized as mild, with the remaining 75% being categorized as moderate or severe. A sickness that is moderate or severe develops in one-third of mild cases.
A further estimate places the annual number of term and late-preterm newborns in the USA with HRF at 80,000. In neonatal intensive care units (NICUs), respiratory morbidity affects about 15% of term newborns and 29% of late-preterm infants. These are the key reasons for the increasing demand for Inhaled Nitric Oxide Delivery Systems in the country.
In 2021, the market size of China is comparatively small. It was the second-largest Inhaled Nitric Oxide Delivery Systems Market after the US. The market in the country is expected to reach a valuation of USD 88.4 million by 2032. From 2017 to 2021, the market in China experienced a CAGR of 9.9% and is expected to experience a CAGR of 10.7% with an absolute dollar opportunity of USD 56.4 million.
With the increasing number of smokers in the country, respiratory diseases are also becoming quite common. In China, almost 1 million people know of COPD, which presents a significant opportunity for INO delivery systems marketers, as inhalation of nitric oxide has been clinically proven to improve the oxygenation of arterial blood flow and limit the amount of mechanical-assisted breathing treatments in patients with the severe acute respiratory syndrome (SARS).
The inhaled nitric oxide delivery systems market in the UK was held at USD 12.3 million in 2021. The market is projected to reach a valuation of USD 37.4 million by 2032. The UK market is expected to witness an absolute dollar opportunity of USD 24 million.
The inhaled nitric oxide delivery systems market in Japan is estimated at USD 9.1 million in 2022. The market in the country is projected to reach a valuation of USD 21.2 million by 2032. From 2022 to 2032, the market is expected to gross an absolute dollar opportunity of USD 12.1 million, growing at a CAGR of 8.8%.
Inhaled Nitric Oxide Delivery Systems are used the most among pediatrics. From 2017 to 2021, the use of INO Delivery Systems among pediatrics experienced a CAGR of 8.9% and is expected to witness a CAGR of 9.8% in the next ten years.
Inhaled nitric oxide has been significantly effective in the treatment of neonatal diseases such as hypoxic respiratory failure (HRF). In the USA alone, over 25,000 to 30,000 newborn HRF cases are recorded each year, wherein Inhaled Nitric Oxide Delivery System is used for treatment to cure more than half of them.
Inhaled Nitric Oxide Delivery Systems are used the most in the treatment of Hypoxic Respiratory Failure. The use of the INO delivery system in the treatment of HRF from the year 2017 to 2021 experienced a CAGR of 8.8% and is projected to experience a CAGR of 9.6% from 2022 to 2032.
In 2020, the treatment of Hypoxic Respiratory Failure using Inhaled Nitric Oxide Delivery Systems made up 80.2% of the overall market. Around 2% of all live births and those affected by HRF is also responsible for more than 33% of all neonatal deaths. The death of 18 out of every 1,000 newborns, the majority of whom are born prematurely in the USA, is due to the HRF. According to studies, Inhaled Nitric Oxide is used as the first line of treatment for HRF and it can be used for more than 10 days without causing complications.
The Inhaled Nitric Oxide Delivery Systems market is moderately competitive and has numerous players. With the growing demand for Inhaled Nitric Oxide Systems, new players are also entering the market. The key companies operating in the Inhaled Nitric Oxide Delivery Systems Market are Mallinckrodt Pharmaceuticals, Getinge, VERO Biotech, LINDE, Beyond Air, SLE, NU MED, Bellerophon Therapeutics, Air Liquide Healthcare, and Circassia Pharmaceuticals.
Some of the recent developments by the key providers of Inhaled Nitric Oxide Delivery Systems are as follows:
Table 1: Global Market Value (US$ million) Forecast by Region, 2017 to 2032
Table 2: Global Market Volume (Units) Forecast by Region, 2017 to 2032
Table 3: Global Market Value (US$ million) Forecast by Type, 2017 to 2032
Table 4: Global Market Volume (Units) Forecast by Type, 2017 to 2032
Table 5: Global Market Value (US$ million) Forecast by Application, 2017 to 2032
Table 6: Global Market Volume (Units) Forecast by Application, 2017 to 2032
Table 7: Global Market Value (US$ million) Forecast by End User, 2017 to 2032
Table 8: Global Market Volume (Units) Forecast by End User, 2017 to 2032
Table 9: Global Market Value (US$ million) Forecast by Product Type, 2017 to 2032
Table 10: Global Market Volume (Units) Forecast by Product Type, 2017 to 2032
Table 11: North America Market Value (US$ million) Forecast by Country, 2017 to 2032
Table 12: North America Market Volume (Units) Forecast by Country, 2017 to 2032
Table 13: North America Market Value (US$ million) Forecast by Type, 2017 to 2032
Table 14: North America Market Volume (Units) Forecast by Type, 2017 to 2032
Table 15: North America Market Value (US$ million) Forecast by Application, 2017 to 2032
Table 16: North America Market Volume (Units) Forecast by Application, 2017 to 2032
Table 17: North America Market Value (US$ million) Forecast by End User, 2017 to 2032
Table 18: North America Market Volume (Units) Forecast by End User, 2017 to 2032
Table 19: North America Market Value (US$ million) Forecast by Product Type, 2017 to 2032
Table 20: North America Market Volume (Units) Forecast by Product Type, 2017 to 2032
Table 21: Latin America Market Value (US$ million) Forecast by Country, 2017 to 2032
Table 22: Latin America Market Volume (Units) Forecast by Country, 2017 to 2032
Table 23: Latin America Market Value (US$ million) Forecast by Type, 2017 to 2032
Table 24: Latin America Market Volume (Units) Forecast by Type, 2017 to 2032
Table 25: Latin America Market Value (US$ million) Forecast by Application, 2017 to 2032
Table 26: Latin America Market Volume (Units) Forecast by Application, 2017 to 2032
Table 27: Latin America Market Value (US$ million) Forecast by End User, 2017 to 2032
Table 28: Latin America Market Volume (Units) Forecast by End User, 2017 to 2032
Table 29: Latin America Market Value (US$ million) Forecast by Product Type, 2017 to 2032
Table 30: Latin America Market Volume (Units) Forecast by Product Type, 2017 to 2032
Table 31: Europe Market Value (US$ million) Forecast by Country, 2017 to 2032
Table 32: Europe Market Volume (Units) Forecast by Country, 2017 to 2032
Table 33: Europe Market Value (US$ million) Forecast by Type, 2017 to 2032
Table 34: Europe Market Volume (Units) Forecast by Type, 2017 to 2032
Table 35: Europe Market Value (US$ million) Forecast by Application, 2017 to 2032
Table 36: Europe Market Volume (Units) Forecast by Application, 2017 to 2032
Table 37: Europe Market Value (US$ million) Forecast by End User, 2017 to 2032
Table 38: Europe Market Volume (Units) Forecast by End User, 2017 to 2032
Table 39: Europe Market Value (US$ million) Forecast by Product Type, 2017 to 2032
Table 40: Europe Market Volume (Units) Forecast by Product Type, 2017 to 2032
Table 41: Asia Pacific Market Value (US$ million) Forecast by Country, 2017 to 2032
Table 42: Asia Pacific Market Volume (Units) Forecast by Country, 2017 to 2032
Table 43: Asia Pacific Market Value (US$ million) Forecast by Type, 2017 to 2032
Table 44: Asia Pacific Market Volume (Units) Forecast by Type, 2017 to 2032
Table 45: Asia Pacific Market Value (US$ million) Forecast by Application, 2017 to 2032
Table 46: Asia Pacific Market Volume (Units) Forecast by Application, 2017 to 2032
Table 47: Asia Pacific Market Value (US$ million) Forecast by End User, 2017 to 2032
Table 48: Asia Pacific Market Volume (Units) Forecast by End User, 2017 to 2032
Table 49: Asia Pacific Market Value (US$ million) Forecast by Product Type, 2017 to 2032
Table 50: Asia Pacific Market Volume (Units) Forecast by Product Type, 2017 to 2032
Table 51: MEA Market Value (US$ million) Forecast by Country, 2017 to 2032
Table 52: MEA Market Volume (Units) Forecast by Country, 2017 to 2032
Table 53: MEA Market Value (US$ million) Forecast by Type, 2017 to 2032
Table 54: MEA Market Volume (Units) Forecast by Type, 2017 to 2032
Table 55: MEA Market Value (US$ million) Forecast by Application, 2017 to 2032
Table 56: MEA Market Volume (Units) Forecast by Application, 2017 to 2032
Table 57: MEA Market Value (US$ million) Forecast by End User, 2017 to 2032
Table 58: MEA Market Volume (Units) Forecast by End User, 2017 to 2032
Table 59: MEA Market Value (US$ million) Forecast by Product Type, 2017 to 2032
Table 60: MEA Market Volume (Units) Forecast by Product Type, 2017 to 2032
Figure 1: Global Market Value (US$ million) by Type, 2022 to 2032
Figure 2: Global Market Value (US$ million) by Application, 2022 to 2032
Figure 3: Global Market Value (US$ million) by End User, 2022 to 2032
Figure 4: Global Market Value (US$ million) by Product Type, 2022 to 2032
Figure 5: Global Market Value (US$ million) by Region, 2022 to 2032
Figure 6: Global Market Value (US$ million) Analysis by Region, 2017 to 2032
Figure 7: Global Market Volume (Units) Analysis by Region, 2017 to 2032
Figure 8: Global Market Value Share (%) and BPS Analysis by Region, 2022 to 2032
Figure 9: Global Market Y-o-Y Growth (%) Projections by Region, 2022 to 2032
Figure 10: Global Market Value (US$ million) Analysis by Type, 2017 to 2032
Figure 11: Global Market Volume (Units) Analysis by Type, 2017 to 2032
Figure 12: Global Market Value Share (%) and BPS Analysis by Type, 2022 to 2032
Figure 13: Global Market Y-o-Y Growth (%) Projections by Type, 2022 to 2032
Figure 14: Global Market Value (US$ million) Analysis by Application, 2017 to 2032
Figure 15: Global Market Volume (Units) Analysis by Application, 2017 to 2032
Figure 16: Global Market Value Share (%) and BPS Analysis by Application, 2022 to 2032
Figure 17: Global Market Y-o-Y Growth (%) Projections by Application, 2022 to 2032
Figure 18: Global Market Value (US$ million) Analysis by End User, 2017 to 2032
Figure 19: Global Market Volume (Units) Analysis by End User, 2017 to 2032
Figure 20: Global Market Value Share (%) and BPS Analysis by End User, 2022 to 2032
Figure 21: Global Market Y-o-Y Growth (%) Projections by End User, 2022 to 2032
Figure 22: Global Market Value (US$ million) Analysis by Product Type, 2017 to 2032
Figure 23: Global Market Volume (Units) Analysis by Product Type, 2017 to 2032
Figure 24: Global Market Value Share (%) and BPS Analysis by Product Type, 2022 to 2032
Figure 25: Global Market Y-o-Y Growth (%) Projections by Product Type, 2022 to 2032
Figure 26: Global Market Attractiveness by Type, 2022 to 2032
Figure 27: Global Market Attractiveness by Application, 2022 to 2032
Figure 28: Global Market Attractiveness by End User, 2022 to 2032
Figure 29: Global Market Attractiveness by Product Type, 2022 to 2032
Figure 30: Global Market Attractiveness by Region, 2022 to 2032
Figure 31: North America Market Value (US$ million) by Type, 2022 to 2032
Figure 32: North America Market Value (US$ million) by Application, 2022 to 2032
Figure 33: North America Market Value (US$ million) by End User, 2022 to 2032
Figure 34: North America Market Value (US$ million) by Product Type, 2022 to 2032
Figure 35: North America Market Value (US$ million) by Country, 2022 to 2032
Figure 36: North America Market Value (US$ million) Analysis by Country, 2017 to 2032
Figure 37: North America Market Volume (Units) Analysis by Country, 2017 to 2032
Figure 38: North America Market Value Share (%) and BPS Analysis by Country, 2022 to 2032
Figure 39: North America Market Y-o-Y Growth (%) Projections by Country, 2022 to 2032
Figure 40: North America Market Value (US$ million) Analysis by Type, 2017 to 2032
Figure 41: North America Market Volume (Units) Analysis by Type, 2017 to 2032
Figure 42: North America Market Value Share (%) and BPS Analysis by Type, 2022 to 2032
Figure 43: North America Market Y-o-Y Growth (%) Projections by Type, 2022 to 2032
Figure 44: North America Market Value (US$ million) Analysis by Application, 2017 to 2032
Figure 45: North America Market Volume (Units) Analysis by Application, 2017 to 2032
Figure 46: North America Market Value Share (%) and BPS Analysis by Application, 2022 to 2032
Figure 47: North America Market Y-o-Y Growth (%) Projections by Application, 2022 to 2032
Figure 48: North America Market Value (US$ million) Analysis by End User, 2017 to 2032
Figure 49: North America Market Volume (Units) Analysis by End User, 2017 to 2032
Figure 50: North America Market Value Share (%) and BPS Analysis by End User, 2022 to 2032
Figure 51: North America Market Y-o-Y Growth (%) Projections by End User, 2022 to 2032
Figure 52: North America Market Value (US$ million) Analysis by Product Type, 2017 to 2032
Figure 53: North America Market Volume (Units) Analysis by Product Type, 2017 to 2032
Figure 54: North America Market Value Share (%) and BPS Analysis by Product Type, 2022 to 2032
Figure 55: North America Market Y-o-Y Growth (%) Projections by Product Type, 2022 to 2032
Figure 56: North America Market Attractiveness by Type, 2022 to 2032
Figure 57: North America Market Attractiveness by Application, 2022 to 2032
Figure 58: North America Market Attractiveness by End User, 2022 to 2032
Figure 59: North America Market Attractiveness by Product Type, 2022 to 2032
Figure 60: North America Market Attractiveness by Country, 2022 to 2032
Figure 61: Latin America Market Value (US$ million) by Type, 2022 to 2032
Figure 62: Latin America Market Value (US$ million) by Application, 2022 to 2032
Figure 63: Latin America Market Value (US$ million) by End User, 2022 to 2032
Figure 64: Latin America Market Value (US$ million) by Product Type, 2022 to 2032
Figure 65: Latin America Market Value (US$ million) by Country, 2022 to 2032
Figure 66: Latin America Market Value (US$ million) Analysis by Country, 2017 to 2032
Figure 67: Latin America Market Volume (Units) Analysis by Country, 2017 to 2032
Figure 68: Latin America Market Value Share (%) and BPS Analysis by Country, 2022 to 2032
Figure 69: Latin America Market Y-o-Y Growth (%) Projections by Country, 2022 to 2032
Figure 70: Latin America Market Value (US$ million) Analysis by Type, 2017 to 2032
Figure 71: Latin America Market Volume (Units) Analysis by Type, 2017 to 2032
Figure 72: Latin America Market Value Share (%) and BPS Analysis by Type, 2022 to 2032
Figure 73: Latin America Market Y-o-Y Growth (%) Projections by Type, 2022 to 2032
Figure 74: Latin America Market Value (US$ million) Analysis by Application, 2017 to 2032
Figure 75: Latin America Market Volume (Units) Analysis by Application, 2017 to 2032
Figure 76: Latin America Market Value Share (%) and BPS Analysis by Application, 2022 to 2032
Figure 77: Latin America Market Y-o-Y Growth (%) Projections by Application, 2022 to 2032
Figure 78: Latin America Market Value (US$ million) Analysis by End User, 2017 to 2032
Figure 79: Latin America Market Volume (Units) Analysis by End User, 2017 to 2032
Figure 80: Latin America Market Value Share (%) and BPS Analysis by End User, 2022 to 2032
Figure 81: Latin America Market Y-o-Y Growth (%) Projections by End User, 2022 to 2032
Figure 82: Latin America Market Value (US$ million) Analysis by Product Type, 2017 to 2032
Figure 83: Latin America Market Volume (Units) Analysis by Product Type, 2017 to 2032
Figure 84: Latin America Market Value Share (%) and BPS Analysis by Product Type, 2022 to 2032
Figure 85: Latin America Market Y-o-Y Growth (%) Projections by Product Type, 2022 to 2032
Figure 86: Latin America Market Attractiveness by Type, 2022 to 2032
Figure 87: Latin America Market Attractiveness by Application, 2022 to 2032
Figure 88: Latin America Market Attractiveness by End User, 2022 to 2032
Figure 89: Latin America Market Attractiveness by Product Type, 2022 to 2032
Figure 90: Latin America Market Attractiveness by Country, 2022 to 2032
Figure 91: Europe Market Value (US$ million) by Type, 2022 to 2032
Figure 92: Europe Market Value (US$ million) by Application, 2022 to 2032
Figure 93: Europe Market Value (US$ million) by End User, 2022 to 2032
Figure 94: Europe Market Value (US$ million) by Product Type, 2022 to 2032
Figure 95: Europe Market Value (US$ million) by Country, 2022 to 2032
Figure 96: Europe Market Value (US$ million) Analysis by Country, 2017 to 2032
Figure 97: Europe Market Volume (Units) Analysis by Country, 2017 to 2032
Figure 98: Europe Market Value Share (%) and BPS Analysis by Country, 2022 to 2032
Figure 99: Europe Market Y-o-Y Growth (%) Projections by Country, 2022 to 2032
Figure 100: Europe Market Value (US$ million) Analysis by Type, 2017 to 2032
Figure 101: Europe Market Volume (Units) Analysis by Type, 2017 to 2032
Figure 102: Europe Market Value Share (%) and BPS Analysis by Type, 2022 to 2032
Figure 103: Europe Market Y-o-Y Growth (%) Projections by Type, 2022 to 2032
Figure 104: Europe Market Value (US$ million) Analysis by Application, 2017 to 2032
Figure 105: Europe Market Volume (Units) Analysis by Application, 2017 to 2032
Figure 106: Europe Market Value Share (%) and BPS Analysis by Application, 2022 to 2032
Figure 107: Europe Market Y-o-Y Growth (%) Projections by Application, 2022 to 2032
Figure 108: Europe Market Value (US$ million) Analysis by End User, 2017 to 2032
Figure 109: Europe Market Volume (Units) Analysis by End User, 2017 to 2032
Figure 110: Europe Market Value Share (%) and BPS Analysis by End User, 2022 to 2032
Figure 111: Europe Market Y-o-Y Growth (%) Projections by End User, 2022 to 2032
Figure 112: Europe Market Value (US$ million) Analysis by Product Type, 2017 to 2032
Figure 113: Europe Market Volume (Units) Analysis by Product Type, 2017 to 2032
Figure 114: Europe Market Value Share (%) and BPS Analysis by Product Type, 2022 to 2032
Figure 115: Europe Market Y-o-Y Growth (%) Projections by Product Type, 2022 to 2032
Figure 116: Europe Market Attractiveness by Type, 2022 to 2032
Figure 117: Europe Market Attractiveness by Application, 2022 to 2032
Figure 118: Europe Market Attractiveness by End User, 2022 to 2032
Figure 119: Europe Market Attractiveness by Product Type, 2022 to 2032
Figure 120: Europe Market Attractiveness by Country, 2022 to 2032
Figure 121: Asia Pacific Market Value (US$ million) by Type, 2022 to 2032
Figure 122: Asia Pacific Market Value (US$ million) by Application, 2022 to 2032
Figure 123: Asia Pacific Market Value (US$ million) by End User, 2022 to 2032
Figure 124: Asia Pacific Market Value (US$ million) by Product Type, 2022 to 2032
Figure 125: Asia Pacific Market Value (US$ million) by Country, 2022 to 2032
Figure 126: Asia Pacific Market Value (US$ million) Analysis by Country, 2017 to 2032
Figure 127: Asia Pacific Market Volume (Units) Analysis by Country, 2017 to 2032
Figure 128: Asia Pacific Market Value Share (%) and BPS Analysis by Country, 2022 to 2032
Figure 129: Asia Pacific Market Y-o-Y Growth (%) Projections by Country, 2022 to 2032
Figure 130: Asia Pacific Market Value (US$ million) Analysis by Type, 2017 to 2032
Figure 131: Asia Pacific Market Volume (Units) Analysis by Type, 2017 to 2032
Figure 132: Asia Pacific Market Value Share (%) and BPS Analysis by Type, 2022 to 2032
Figure 133: Asia Pacific Market Y-o-Y Growth (%) Projections by Type, 2022 to 2032
Figure 134: Asia Pacific Market Value (US$ million) Analysis by Application, 2017 to 2032
Figure 135: Asia Pacific Market Volume (Units) Analysis by Application, 2017 to 2032
Figure 136: Asia Pacific Market Value Share (%) and BPS Analysis by Application, 2022 to 2032
Figure 137: Asia Pacific Market Y-o-Y Growth (%) Projections by Application, 2022 to 2032
Figure 138: Asia Pacific Market Value (US$ million) Analysis by End User, 2017 to 2032
Figure 139: Asia Pacific Market Volume (Units) Analysis by End User, 2017 to 2032
Figure 140: Asia Pacific Market Value Share (%) and BPS Analysis by End User, 2022 to 2032
Figure 141: Asia Pacific Market Y-o-Y Growth (%) Projections by End User, 2022 to 2032
Figure 142: Asia Pacific Market Value (US$ million) Analysis by Product Type, 2017 to 2032
Figure 143: Asia Pacific Market Volume (Units) Analysis by Product Type, 2017 to 2032
Figure 144: Asia Pacific Market Value Share (%) and BPS Analysis by Product Type, 2022 to 2032
Figure 145: Asia Pacific Market Y-o-Y Growth (%) Projections by Product Type, 2022 to 2032
Figure 146: Asia Pacific Market Attractiveness by Type, 2022 to 2032
Figure 147: Asia Pacific Market Attractiveness by Application, 2022 to 2032
Figure 148: Asia Pacific Market Attractiveness by End User, 2022 to 2032
Figure 149: Asia Pacific Market Attractiveness by Product Type, 2022 to 2032
Figure 150: Asia Pacific Market Attractiveness by Country, 2022 to 2032
Figure 151: MEA Market Value (US$ million) by Type, 2022 to 2032
Figure 152: MEA Market Value (US$ million) by Application, 2022 to 2032
Figure 153: MEA Market Value (US$ million) by End User, 2022 to 2032
Figure 154: MEA Market Value (US$ million) by Product Type, 2022 to 2032
Figure 155: MEA Market Value (US$ million) by Country, 2022 to 2032
Figure 156: MEA Market Value (US$ million) Analysis by Country, 2017 to 2032
Figure 157: MEA Market Volume (Units) Analysis by Country, 2017 to 2032
Figure 158: MEA Market Value Share (%) and BPS Analysis by Country, 2022 to 2032
Figure 159: MEA Market Y-o-Y Growth (%) Projections by Country, 2022 to 2032
Figure 160: MEA Market Value (US$ million) Analysis by Type, 2017 to 2032
Figure 161: MEA Market Volume (Units) Analysis by Type, 2017 to 2032
Figure 162: MEA Market Value Share (%) and BPS Analysis by Type, 2022 to 2032
Figure 163: MEA Market Y-o-Y Growth (%) Projections by Type, 2022 to 2032
Figure 164: MEA Market Value (US$ million) Analysis by Application, 2017 to 2032
Figure 165: MEA Market Volume (Units) Analysis by Application, 2017 to 2032
Figure 166: MEA Market Value Share (%) and BPS Analysis by Application, 2022 to 2032
Figure 167: MEA Market Y-o-Y Growth (%) Projections by Application, 2022 to 2032
Figure 168: MEA Market Value (US$ million) Analysis by End User, 2017 to 2032
Figure 169: MEA Market Volume (Units) Analysis by End User, 2017 to 2032
Figure 170: MEA Market Value Share (%) and BPS Analysis by End User, 2022 to 2032
Figure 171: MEA Market Y-o-Y Growth (%) Projections by End User, 2022 to 2032
Figure 172: MEA Market Value (US$ million) Analysis by Product Type, 2017 to 2032
Figure 173: MEA Market Volume (Units) Analysis by Product Type, 2017 to 2032
Figure 174: MEA Market Value Share (%) and BPS Analysis by Product Type, 2022 to 2032
Figure 175: MEA Market Y-o-Y Growth (%) Projections by Product Type, 2022 to 2032
Figure 176: MEA Market Attractiveness by Type, 2022 to 2032
Figure 177: MEA Market Attractiveness by Application, 2022 to 2032
Figure 178: MEA Market Attractiveness by End User, 2022 to 2032
Figure 179: MEA Market Attractiveness by Product Type, 2022 to 2032
Figure 180: MEA Market Attractiveness by Country, 2022 to 2032
The global Inhaled Nitric Oxide Delivery Systems Market was valued at USD 273.7 million in 2021 and is expected to account for an absolute dollar opportunity of USD 438.4 million by 2032.
Over the projected period, the Inhaled Nitric Oxide Delivery Systems Market is expected to increase at a CAGR of 9.5%, reaching a value of USD 735.7 million by 2032.
The growing number of respiratory diseases among all age groups especially during the pandemic is driving the market for Inhaled Oxide Delivery Systems.
The Inhaled Nitric Oxide Delivery Systems Market expanded at a CAGR of 8.5% from 2017 through 2021.
Mallinckrodt Pharmaceuticals, Getinge, Vero Biotech, LINDE, Beyond Air, SLE, NU MED, Bellerophon Therapeutics, Air Liquide Healthcare, and Circassia Pharmaceuticals, are some of the key players in the Inhaled Nitric Oxide Delivery Systems Industry.
The USA, UK, China, Japan, and South Korea are expected to drive the most Inhaled Nitric Oxide Delivery Systems.
The US accounts for the largest market for Inhaled Nitric Oxide Delivery Systems.
Explore Therapeutic Device Insights
Inhaled Nitric Oxide Delivery Systems Market
Thank you!
You will receive an email from our Business Development Manager. Please be sure to check your SPAM/JUNK folder too.
